BioSpace News Archive

Women of Color in Pharma (WOCIP) will hold its second annual conference Nov. 2 and 3 at The Westin in Princeton, N.J. Women of color from every level and function in the pharmaceutical sector will attend sessions led by industry leaders, innovators and business veterans.

MyHealthDirect, a leading provider of digital care coordination solutions, announced today that Beacon Health System, the regional leader in world-class care throughout North Central Indiana and Southwestern Michigan, has selected the company’s solutions to enhance patient access.

Volpara Health Technologies (VHT), the industry leader in breast imaging analytics, announced today that the company has achieved ISO/IEC 27001:2013 Information Security Management System (ISMS) certification, confirming that VHT and all its subsidiaries and related products comply with the highest data security standards.

DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that its LVivo EF cardiac decision-support software is now available for purchase for GE’s new Vscan Extend™ handheld, pocket-sized ultrasound.

Actinium Pharmaceuticals, Inc., (NYSE American: ATNM) (“Actinium” or “the Company”), announced today that it will unveil a new clinical initiative that expands the Company’s pipeline into the CAR-T space.

Wolters Kluwer, Health and Omnicell, Inc. (NASDAQ: OMCL) today announced that Connecticut-based Middlesex Hospital has extended its use of Simplifi 797® and has chosen Omnicell’s IVX Workflow to automate the hospital’s sterile compounding operations.

DURECT Corporation (Nasdaq: DRRX) today announced that Orient Pharma Co., Ltd., its licensee for certain Asian and South Pacific countries, has informed DURECT that it has obtained marketing authorization from the Ministry of Health and Welfare in Taiwan for Methydur Sustained Release Capsules.

Mr. Kilcoyne brings more than 30 years of experience in the medical device market to the Cerus Endovascular Board.

LEO Science & Tech Hub, the Boston-based R&D innovation unit of LEO Pharma, has announced a new partnership with Epicore Biosystems focused on exploring the use of a non-invasive, wearable sweat sensor to measure prognostic biomarkers in real time, monitor patient response and inform treatment decisions.

Analytics 4 Life, a digital health company dedicated to improving existing diagnostic pathways, today announced that clinical data will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium.